700 Shares in Encompass Health Co. (NYSE:EHC) Purchased by Morse Asset Management Inc

Morse Asset Management Inc acquired a new position in shares of Encompass Health Co. (NYSE:EHC) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 700 shares of the company’s stock, valued at approximately $68,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. QRG Capital Management Inc. increased its position in Encompass Health by 85.6% during the second quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock worth $1,232,000 after purchasing an additional 6,627 shares during the last quarter. SG Americas Securities LLC acquired a new stake in Encompass Health during the second quarter worth about $2,204,000. Los Angeles Capital Management LLC increased its position in Encompass Health by 532.4% during the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after purchasing an additional 42,338 shares during the last quarter. Pathstone Holdings LLC increased its position in Encompass Health by 54.5% during the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after purchasing an additional 7,412 shares during the last quarter. Finally, Deerfield Management Company L.P. Series C acquired a new stake in Encompass Health during the second quarter worth about $541,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Trading Down 0.1 %

Shares of EHC stock opened at $102.37 on Thursday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The stock has a market capitalization of $10.31 billion, a P/E ratio of 24.73, a price-to-earnings-growth ratio of 1.35 and a beta of 0.86. The company has a 50 day moving average price of $98.50 and a 200 day moving average price of $91.69. Encompass Health Co. has a fifty-two week low of $64.15 and a fifty-two week high of $104.55.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the previous year, the firm earned $0.86 earnings per share. The firm’s quarterly revenue was up 11.9% on a year-over-year basis. Equities research analysts predict that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.66%. Encompass Health’s dividend payout ratio (DPR) is 16.43%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on EHC. Truist Financial restated a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. UBS Group lifted their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. KeyCorp lifted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada lifted their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Finally, Barclays lifted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.